The San Diego biotechnology company Nanogen said yesterday that it has filed for bankruptcy protection with plans to sell off nearly all its assets to the French company Elitech Group. The Chapter 11 ...

ELITech Molecular Diagnostics has announced it has received FDA clearance for its methicillin-resistant Staphylococcus aureus/Staphylococcus aureus ELITe MGB test, according to a news release. The ...

French medical company The Elitech Group will invest at least $2 million in Broomfield-based Corgenix Medical Corp. as part of a strategic alliance that officials say is possibly the “most important ...

Mirina, the new entity, gained Nanogen’s technology that aims to enhance miRNA drugs. Nanogen and The Elitech Group entered a definitive merger agreement. Separately, Nanogen also created a technology ...

ELITech is an in-vitro diagnostic company Hospitals and laboratories in more than 100 countries use ELITech’s products PAI invested in the business in 2017 UPDATED. PAI Partners will hit a 3.7x gross ...

DENVER and PARIS, July 19 Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, and the ELITech Group, a Paris, France-based, privately ...

Holzgerlingen, Germany, March 6, 2013 -- Curetis AG today announced the appointment of Helmut Hilbert as Head of Business Development and the expansion of its distribution network into Belgium and ...

Upon completion of the transaction, ELITech is expected to operate as a stand-alone entity within Bruker’s Microbiology and Infection Diagnostics division. Bruker plans to fund the acquisition with ...

TORINO, Italy--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) announced today that it has entered into a definitive share purchase agreement with TecFin S.à r.l., a controlled affiliate of PAI ...